amantadine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burger, H | 1 |
| Mathijssen, RH | 1 |
| Sparreboom, A | 1 |
| Wiemer, EA | 1 |
| Forchap, SL | 1 |
| Pirmohamed, M | 1 |
| Clark, RE | 1 |
2 other studies available for amantadine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Can "specific" OCT1 inhibitors be used to determine OCT1 transporter activity toward imatinib?
Topics: Amantadine; Analgesics, Non-Narcotic; Antineoplastic Agents; Benzamides; Biological Transport, Activ | 2013 |
Release of intracellular calcium primes chronic myeloid leukaemia cells for tyrosine kinase inhibitor-induced apoptosis.
Topics: Amantadine; Apoptosis; Calcium; Caspases; Cell Membrane Permeability; Drug Synergism; Humans; K562 C | 2012 |